Excited to have metronomic Dac/ Ven in TP53 MDS / AML from our group @MontefioreNYC lead by @MendelGoldfing2 in @Haematologica . ORR of 70% in AML with 11.6 median OS in TP53 mutant AML , 10.4 mos median OS in bialleilic TP53! A step in the right direction! 🎉#leusm #leukemia
Improved outcomes in TP53-mutated MDS/AML without added toxicity.View quoted post on X
Metronomic decitabine /venetoclax. Haematologica doi.org/10.3324/haemat…
@Amitvermamds @aditishasMD @YannisMantz @Saunthararajah @SteidlUli @mkonople @EinsteinMed @MontefioreNYC